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Abstract
Background: Glioma differentiation therapy is a novel strategy that has been used to induce glioma cells to
differentiate into glia-like cells. Although some advances in experimental methods for exploring the molecular
mechanisms involved in differentiation therapy have been made, a model-based comprehensive analysis is still
needed to understand these differentiation mechanisms and improve the effects of anti-cancer therapeutics. This
type of analysis becomes necessary in stochastic cases for two main reasons: stochastic noise inherently exists in
signal transduction and phenotypic regulation during targeted therapy and chemotherapy, and the relationship
between this noise and drug efficacy in differentiation therapy is largely unknown.
Results: In this study, we developed both an additive noise model and a Chemical-Langenvin-Equation model for
the signaling pathways involved in glioma differentiation therapy to investigate the functional role of noise in the
drug response. Our model analysis revealed an ultrasensitive mechanism of cyclin D1 degradation that controls the
glioma differentiation induced by the cAMP inducer cholera toxin (CT). The role of cyclin D1 degradation in human
glioblastoma cell differentiation was then experimentally verified. Our stochastic simulation demonstrated that noise
not only renders some glioma cells insensitive to cyclin D1 degradation during drug treatment but also induce
heterogeneous differentiation responses among individual glioma cells by modulating the ultrasensitive response of
cyclin D1. As such, the noise can reduce the differentiation efficiency in drug-treated glioma cells, which was
verified by the decreased evolution of differentiation potential, which quantified the impact of noise on the
dynamics of the drug-treated glioma cell population.
Conclusion: Our results demonstrated that targeting the noise-induced dynamics of cyclin D1 during glioma
differentiation therapy can increase anti-glioma effects, implying that noise is a considerable factor in assessing and
optimizing anti-cancer drug interventions.
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Background
Glioma differentiation therapy is a novel strategy for indu-
cing glioma cells to differentiate into normal-like cells
using specific drugs [1]. Although some advances in ex-
ploring the molecular mechanisms involved in drug-
induced glioma differentiation have been made, a model-
based comprehensive analysis is still needed to understand
these differentiation mechanisms and improve the effects
of anti-cancer therapeutics.
Experimental studies have revealed a variety of signal-
ing pathways that are involved in the regulation of gli-
oma differentiation. It has been shown that the elevation
of cAMP levels by cholera toxin (CT) can induce glioma
cell differentiation, which is mediated by CREB phos-
phorylation at Ser-133 in a PKA dependent manner [2].
cAMP/PKA signaling can also inhibit the PI3K/AKT
pathway, leading to the activation of the downstream
molecule GSK-3β and subsequent degradation of cyclin
D1 [3]. Additionally, the IL-6/JAK2/STAT3 pathway,
which is activated by increased cAMP levels, is also in-
volved in glioma cell differentiation [4]. In such studies,
Glial fibrillary acidic protein (GFAP) is applied as a reli-
able marker for evaluating the differentiation of glioma
cells.
Mathematical models have shown great potential in
contributing to the understanding of biological mecha-
nisms and the generation of testable hypotheses or pre-
dictions. In a recent study [5], we constructed an
ordinary differential equation (ODE) model for the sig-
naling network involved in glioma differentiation which
revealed a bi-stable mechanism for phenotype switching
during glioma differentiation. On the other hand, exten-
sive stochastic noise exists in signal transduction and
phenotypic regulation [6] and biological regulatory sys-
tems are dynamic and stochastic. Several studies have
demonstrated an intricate interplay between noise and
the structure and spatiotemporal dynamics [7] of the sig-
naling network [8, 9] during cancer therapy. However,
few studies have examined the relationship between in-
herent noise and drug efficacy in the induction of glioma
differentiation.
In the present study, we adopted glioma differentiation
therapy as a realistic case for investigating how the noise
that inevitably exists in signaling networks influences
drug efficacy and contributes to drug resistance, focusing
on the functional role of this noise in the drug response
of glioma cancer cells. We developed both an additive
noise model (ANM) and a Chemical-Langenvin-
Equation (CLE) model to simulate the stochastic dynam-
ics of the signaling network during glioma differentiation
therapy. We showed that the increase in noise due to
the ultrasensitive response of cyclin D1 in response to
drug treatment can induce bifurcation and heteroge-
neous responses in glioma differentiation. As such, this
noise may reduce drug efficacy in the induction of gli-
oma differentiation. Our model further demonstrated
that a feedback loop of cyclin D1 activation can increase
the variability in signal transduction and phenotypic
transition. The results suggest that interventions inhibit-
ing cyclin D1 feedback could help to enhance drug-
induced differentiation efficiency in a noisy environment
during glioma differentiation therapy.
Results
Ultrasensitive response of cyclin D1 controls
drug-induced glioma differentiation
Based on a validated set of parameter values obtained by
fitting experimental data [5], we performed parameter a
sensitivity analysis (see Methods) to investigate which of
the parameters in the developed signaling network
model (Fig. 1) were most sensitive or critical for glioma
differentiation. The value of each parameter was in-
creased by 5 % from its estimated value, and the time-
averaged percent change in the level of GFAP was then
obtained. The computations were repeated 20 times, and
the mean value and standard deviation were then calcu-
lated (Fig. 2a). It was observed that among all of the pa-
rameters, two cyclin D1-associated parameters, K6a (the
Michaelis constant for self-feedback of cyclin D1), and
d6 (the deactivation rate of cyclin D1 induced by active
GSK3β) were the most sensitive to small variations.
These sensitive parameters indicate the critical role of
cyclin D1 in regulating glioma differentiation.
The quantified experimental data [2, 3] showed the
dose responses of cyclin D1 and GFAP to CT. Our simu-
lation (Fig. 2b) using the validated model further indi-
cated a rapid decrease in the response of cyclin D1 as
well as a steep rise in the response of GFAP to increasing
CT stimulation within a narrow range (6 to 7 ng/ml).
This is a characteristic indication of “ultrasensitivity” in
the dose-response relationship [10, 11]. Therefore, we
employed an “apparent Hill coefficient” [12, 13] to
quantitatively evaluate whether the response of glioma
differentiation is ultrasensitive to CT. This Hill coeffi-
cient is defined by the following equation [12, 13]:
H ¼ ln81= ln EC90=EC10ð Þ; ð1Þ
where EC90 and EC10 represent the stimuli that generate
90 and 10 % of the maximal response, respectively. The
apparent Hill coefficients of the simulated dose-response
curves for cyclin D1 and GFAP with respect to CT were
40 and 43, respectively (Fig. 2b), indicating strong ultra-
sensitivity in the response of glioma differentiation to
drug treatment. These results demonstrated that the dy-
namics of differentiation-associated protein activation
(i.e. cyclin D1 and GFAP activation) might be regulated
by an ultrasensitive mechanism through which low drug
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levels induce minimal cyclin D1 degradation and GFAP
activation but degradation/activation is strongly induced
once the drug dose increases above a threshold. Fig. 2c
further shows the time-course of cyclin D1 and GFAP
following drug treatment (CT = 10 ng/ml) in the deter-
ministic model.
We then experimentally tested the regulatory role of
cyclin D1 in the differentiation of human malignant gli-
oma cells (U87-MG cells) by silencing CCND1, which
encodes cyclin D1 protein, and pharmacologically down-
regulating or inhibiting cyclin D1. We selected the most
efficient siRNA fragment 003 to knockdown CCND1
(Additional file 1: Figure S1a). Knockdown of CCND1
induced GFAP expression, accompanied by downregula-
tion of proliferating cell nuclear antigen (PCNA, a
marker for cell proliferation) (Additional file 1: Figure
S1b). Additionally, we used the cAMP analogue 8-CPT-
cAMP to mimic the inhibitory effect of cAMP signal ac-
tivators such as cholera toxin and forskolin on cyclin D1
protein [2, 14]. As shown in Additional file 1: Figure
S1c, 8-CPT-cAMP triggers downregulation of cyclin D1,
leading to a significant increase in GFAP, but a decrease
in PCNA. To further demonstrate the regulatory role of
cyclin D1 in the glia-fate induction of glioma cells, we
introduced a functional pharmacologic inhibitor of
CDK4 and 6 which bind to cyclin D1 to form a complex
required for G1-S cell cycle phase progression [15]. The
CDK4/6 inhibitor induced the same changes in GFAP
and PCNA as siCCND1 and 8-CPT-cAMP (Additional
file 1: Figure S1c). Moreover, all of the applied strategies
targeting cyclin D1 were able to transform the polygonal
bodies of U87-MG cells into a glia-like morphology with
dramatically extended processes (Additional file 1: Figure
S1d). These data demonstrate the role of cyclin D1 in gli-
oma differentiation, in accordance with the characteristics
of our model.
Noise-induced heterogeneous response of glioma
differentiation
Here, we investigated the stochastic dynamics of cyclin
D1 and GFAP concentrations in a noisy environment.



















Fig. 1 Signaling network of drug-induced glioma differentiation. Signaling pathways involved in the regulation of glioma differentiation during
glioma differentiation. Elevation of cAMP level by cholera toxin (CT), can induce glioma cell differentiation, which is mediated by CREB
phosphorylation at Ser-133 in a PKA dependent manner [2]. cAMP/PKA signaling can also inhibit the PI3K/AKT pathway, leading to activation of
the downstream molecule GSK-3β and subsequent degradation of cyclin D1 [3]. Additionally, the IL-6/JAK2/STAT3 pathway, which is activated
by increased cAMP levels, is also involved in glioma cell differentiation [4]. Glial fibrillary acidic protein (GFAP) is used as a reliable marker for
evaluating the differentiation of glioma cells
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(Fig. 3) showed the temporal evolution of cyclin D1 and
GFAP activation at different noise intensities (σ in the
ANM model is set to 0.1, 1, 5 or 10 %, as in Ref. [16]).
Additional file 1: Figure S2 shows good agreement be-
tween the experimental data and simulated GFAP levels
at a 5 % noise intensity. We found that increasing the
noise intensity impacted the dynamics and distributions
of both the cyclin D1 and GFAP responses (Fig. 3,
Fig. 4a–d). Meanwhile, the simulations using the CLE
model (Fig. 5e–f, i–j) further demonstrated that with an
increase of the intrinsic/extrinsic noise intensity, not all
trajectories of cyclin D1 are downregulated by CT, and
not all trajectories of GFAP are upregulated. This im-
plies that increasing noise strength in signal transduction
can induce bifurcation of cyclin D1 degradation, which
renders some glioma cells insensitive to drug treatment
and induces heterogeneous activation of GFAP. These
results indicate that noise can modulate the ultrasensi-
tive response of cyclin D1 and induce heterogeneous
drug responses of glioma cells during differentiation
therapy.
Increasing noise leads to a reduction of the
differentiation efficiency
We next examined the noise-induced qualitative changes
in cyclin D1 and GFAP in glioma cells. As simulated
using the ANM (Fig. 4a–d) and CLE (Fig. 5c, g, k)
models, an increase in the noise intensity affected the
probabilistic distribution of GFAP, indicating that the
frequency of the higher levels of GFAP equilibrium de-
creases with the increase of noise intensity.
To understand how noise impacts the dynamics of the
drug-treated glioma cell population, we define the differ-
entiation potential (D) as the percent differentiation of
glioma cells induced during drug treatment. That is,
D tð Þ ¼
Z
u xð ÞpGFAP x; tð Þdx; ð2Þ
where pGFAP(x, t) is the probability distribution function
(PDF) describing the concentration (x) of GFAP across a
population, and u(x) is a microscopic indictor function
describing the effect of the drug on the differentiation of
glioma cells at a given GFAP level. Note that u(x) may
be defined as a Heaviside function, such that glioma cells
are able to differentiate only if GFAP levels exceed a crit-
ical value, xc. That is, u(x) =1 if x > xc and u(x) =0 other-
wise. xc is set to 0.8 in this work.
Figure 4e-h shows 20 realizations (green lines) of the
stochastic temporal evolution of the differentiation po-
tential of glioma cells simulated using the ANM model.
The red line represents the mean value, and the standard































































Fig. 2 Ultrasensitive response of cyclin D1 controls the phenotypic transition of drug-induced glioma differentiation. a The sensitivity analysis revealed
that cyclin D1 critically regulates glioma differentiation. b Activation levels of cyclin D1 and GFAP under treatment with increasing doses of CT for 48 h.
Lines represent simulations (green - cyclin D1; red - GFAP), and dots are experimental data (blue - cyclin D1; brown - GFAP). The apparent Hill coefficients
(nH) of the simulated dose-response curves of cyclin D1 and GFAP are 40 and 43, respectively, indicating an ultrasensitive response of glioma differentiation
to drug treatment. c Time-courses of cyclin D1 (green) and GFAP (red) following drug treatment (CT = 10 ng/ml)
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deviations are shown with blue error bars at different
time points in each situation. As the noise intensity in-
creases, the differentiation potential is significantly re-
duced, indicating that drug efficacy in inducing glioma
differentiation is decreased. These results imply that
intra- or extracellular noise or, more generally, complex
signaling interference, could reduce the differentiation
efficiency of drug-treated glioma cells during differenti-
ation therapy.
We also used the CLE model to investigate the effects of
intrinsic and extrinsic noise on the differentiation poten-
tial. Figure 5 shows the stochastic temporal responses of
cyclin D1 and GFAP, the distribution of GFAP levels and
the differentiation potential of glioma cells evaluated after
48 h of drug treatment (CT = 10 ng/ml). In the control





=0.001, and the extrinsic noise has a stand-
ard deviation of λ = 0.001. We then increased the strength
noise intensity= 0.1% noise intensity = 1% noise intensity=5% noise intensity= 10% 




























































































































































Fig. 4 Stochastic cellular responses of glioma cells to differentiation therapy simulated using the ANM model with different noise intensities. The
noise intensity was set at 0.1, 1, 5 or 10 %. The upper panel a, b, c, d shows the probabilistic distribution of GFAP at 48 h during drug treatment
(CT = 10 ng/ml) at different noise intensities. The lower panel e, f, g, h shows the stochastic temporal evolution of the differentiation potential of
the glioma cell population at different noise intensities
noise intensity = 0.1% noise intensity = 1% noise intensity = 5% noise intensity = 10% 






































































































































Fig. 3 Heterogeneous response of cyclin D1 and GFAP in glioma cells simulated using the ANM model. The simulated cells were subjected to
continuous stimulation with CT (10 ng/ml) for 48 h. The stochastic evolution of cyclin D1 and GFAP activity was simulated with different noise
intensities (0.1 % (a, b), 1 % (c, d), 5 % (e, f) and 10 % (g, h), respectively) of signal variation
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=0.01) (Fig. 5e–h). When these
two groups were compared, we found that elevation of the
strength of intrinsic noise resulted in the increased hetero-
geneity of molecular and cellular responses and a de-
creased differentiation potential. A similar effect was
observed for extrinsic noise, as shown in Fig. 5i–l, where
the strength of extrinsic noise was increased from λ =
0.001 to λ = 0.01, which also resulted in a decrease in the
differentiation potential. Furthermore, a comprehensive
investigation of the effects of the combined strength of in-
trinsic and extrinsic noise over a wide range (Fig. 6a)
clearly showed that increasing the intrinsic and/or extrin-
sic noise leads to a reduction of the differentiation
efficiency.
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Fig. 5 Effects of intrinsic and extrinsic noises on the molecular and cellular responses simulated using the CLE model. a-d Control group: the









=0.01); i-l increasing strength of extrinsic noise (λ = 0.01). The stochastic temporal responses of cyclin D1 and GFAP, the
distribution of GFAP levels and the differentiation potential of glioma cells evaluated at 48 h were simulated
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Inhibition of cyclin D1 feedback leads to enhancement of
the differentiation efficiency
Positive feedback of cyclin D1 activation (e.g., through
cyclin D1 auto-activation or the cyclin D1/CDK4-6/Rb/
E2F/cyclin D1 feedback loop [17, 18]) has been demon-
strated to be involved in glioma differentiation [5]. We
investigated whether inhibiting the cyclin D1 feedback
loop could enhance the differentiation efficiency. The ef-
fect of interventions blocking cyclin D1 feedback is sim-
ulated by increasing the value of the Michaelis constant
(K6a) in feedback loop by 2-, 5- or 10-fold. We first used
both the ANM model (Additional file 1: Figure S4) and
the CLE model (Additional file 1: Figure S5) to simulate
the stochastic responses of cyclin D1 and GFAP in CT-
treated cells, with strong or weak cyclin D1 feedback.
The noise intensity in the ANM model was set to 5 % to
illustrate a typical simulation (Additional file 1: Figure





and the strength of extrinsic noise was λ = 0.01. Both
Additional file 1: Figure S4 and Additional file 1: Figure
S5 show that, compared with the single CT treatment,
the combining therapy using CT and inhibition of cyclin
D1 feedback results in a rapid degradation of cyclin D1
and the consistent increase of GFAP activity, with de-
creased heterogeneities in both cyclin D1 and GFAP re-
sponses. We used other methods to investigate the role
of the cyclin D1 feedback loop as well: (1) decreasing
the Hill coefficient of feedback (n2) by 0.2- or 0.5- fold
and (2) decreasing the activation rate of the self-
feedback of cyclin D1 by 0.2- and 0.5- fold in the model.
The results obtained using both of these two methods
were consistent with the previous findings.
We also ran the CLE model with a large range of in-
trinsic and extrinsic noise strengths (from 10-3 to 10-1)
to examine the effect of inhibition of cyclin D1 feedback
on the differentiation potential (Fig. 6). The differenti-
ation potential of CT-treated cells in the presence of
strong (Fig. 6a) and weak (Fig. 6b) cyclin D1 feedback
were examined. Comparison of these two situations
demonstrated that inhibition of cyclin D1 feedback en-
hances the differentiation potential of CT-treated glioma
cells. These results imply that inhibiting the cyclin D1
feedback loop might help to reduce noise-induced drug
resistance and improve the anti-cancer effects of glioma
differentiation therapy.
Discussion
In this study, we developed a stochastic model of the
signaling pathways involved in glioma differentiation
therapy to analyze the functional role of noise in the
drug response of glioma cells to differentiation inducers.
Our analysis indicated that noise can interfere with the
ultrasensitive response of cyclin D1 and reduce the dif-
ferentiation efficiency by inducing heterogeneous re-
sponses of glioma cells to drugs. The ultrasensitive
response of cyclin D1 is brought about through positive
feedback, as inhibiting the feedback loop of cyclin D1 re-
sults in rapid degradation of cyclin D1, even without CT
treatment. As such, the ultrasensitive mechanism in-
volved in the cyclin D1 response to CT would not exist
if this positive feedback loop were blocked. In addition,
our simulation suggested that the combination of differ-
entiation therapies with cyclin D1 feedback inhibition
might improve therapeutic efficacy.
Noise is an inherent feature of dynamic and stochastic
biological systems (e.g., cancer). Whether noise is “bene-
ficial” or “harmful” to a cellular function is an interesting
topic, about which there has been some controversy in
a b
Fig. 6 Differentiation potential simulated using the CLE model with a wide range of intrinsic and extrinsic noise strengths. The combined intrinsic
and extrinsic noise strength in the range of 10-3 to 10-1 was examined. a The differentiation potential of CT-treated glioma cells. b The
differentiation potential of glioma cells treated with CT combined with inhibition of cyclin D1 feedback. The results were evaluated at 48 h.
The inhibition of cyclin D1 feedback was simulated by increasing the value of the Michaelis constant (K6a) of the cyclin D1 feedback loop by
10-fold in the CLE model
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previous studies [19]. Functional noise is thought to be
based on mechanisms intrinsic to network structure or
biological systems themselves. In this study, we revealed
that cyclin D1 ultrasensitivity might result in qualitative
modification of the probability distribution of glioma cell
differentiation due to the stochastic noise in molecular
processes [20]. This noise may include statistical mech-
anical fluctuations in protein activation (intrinsic noise)
[21] and extracellular micro-environmental perturbations
(extrinsic noise) [20]. In this context, innate intra- or
extracellular noise might be utilized by glioma tumor cells
to resist drugs, which may reflect the inherent adaptation
characteristics and acquired fitness of cancers.
Drug resistance is often a major cause of the failure of
chemotherapy [22]. The paradigms surrounding drug-
resistance mechanisms have focused on understanding
drug resistance at the molecular, cellular, and micro-
environmental levels. A well established paradigm for
the mechanisms underlying drug resistance is that a
variety of newly acquired genetic and epigenetic modifi-
cations can render tumor cells insensitive to therapeutic
agents [23]. Another paradigm that is more often ob-
served in various cancer studies involving targeted ther-
apy is that subtle posttranslational activations of
signaling pathways that bypass the stress of the thera-
peutic target can modulate the expression patterns of
oncogenes [24–26]. It has been demonstrated that
micro-environmental adaptations [27] play an import-
ant role in promoting the rapid emergence of acquired
drug resistance due to the drug-induced secretion of
various resistance factors from tumor cells [28, 29].
These studies have provided us with abundant informa-
tion allowing us to understand and potentially over-
come drug resistance.
Our modeling experiments highlighted the possibility
that the dynamic and stochastic features of post-
translational modifications [30] of protein activation
might also reduce drug efficacy, thus facilitating drug re-
sistance, independent of genetic mutations. The post-
translational mechanism underlying the activity of the
cyclin D1 protein revealed in this study is consistent
with experimental data (referring to Fig. 5 in Ref. [3],
showing that cellular cyclin D1 protein levels are re-
markably reduced, while the mRNA levels of cyclin D1
remain unaltered following treatment with CT).
The ANM model includes constant noise that is inde-
pendent of protein concentrations. The noise term in
the ANM model does not take into account the origin of
the randomness in biochemical reactions and does not
have the capacity to describe intrinsic fluctuations,
which is not sufficient in many cases as discussed in
Refs. [31, 32]. Additionally, as a multiplicative from of
noise, the noise term in the CLE model that approxi-
mates the chemical master equation depends on protein
concentrations, and therefore appropriately describes the
intrinsic noise coming from biochemical reactions. The
difference between the ANM and CLE models might
lead to discrepancies in their simulation results. For ex-
ample, in the present study, when the inhibition of cyc-
lin D1 feedback was simulated, the CLE model clearly
showed a significantly higher steady-state GFAP level
(Additional file 1: Figure S5b) compared with the wild-
type (Additional file 1: Figure S5a), while in ANM
model, additive noise introduced fluctuations as only
small oscillations of the steady-state of cyclin D1 and
GFAP, which triggered transition of the steady-states in
some trajectories of cyclin D1 from high to low and
thus, those of GFAP from low to high (Additional file 1:
Figure S4a), due to the irreversible “one-way switch”
mechanism [5]. Therefore, in the ANM model, the aver-
aged steady-state of GFAP in the wild-type (Additional
file 1: Figure S4a) was almost as high as that observed
when cyclin D1 feedback was inhibited (Additional file
1: Figure S4b).
To further verify the correlation between the level of
noise in the cyclin D1 protein concentration and the dif-
ferentiation rate of glioma cells, we will utilize time-
lapse microscopy and a customized cell tracking system
to monitor the degradation of cyclin D1 and the levels
of the differentiation marker GFAP in thousands of indi-
vidual cells under exposure to cholera toxin at a series
of effective doses (5 to 10 ng/ml) [2]. Specifically, the de-
tailed design of the experimental procedure will be as
follows: (1) Cell lines. C6 rat glioma cells will be ob-
tained from the American Type Culture Collection
(Manassas, VA, USA) and maintained in DMEM (Invitro-
gen, Grand Island, NY, USA) supplemented with 10 %
FBS in a humidified atmosphere of 5 % CO2 at 37 °C [2].
(2) Constructs. CCND1 cDNA-red fluorescent protein
(RFP) fusions and GFAP cDNA-green fluorescent protein
(GFP) fusions will be constructed and transduced into C6
cells. After sorting via flow cytometry, pure populations
expressing the desired fluorescent reporters will be ob-
tained and used to establish stable cell strains expressing
cyclin D1 and GFAP with fluorescent proteins. (3) Drug
treatment. Cells from the stable cell strains will be ex-
posed to cholera toxin (Sigma, St Louis, MO, USA) at ef-
fective concentrations of 5, 6, 7, 8, 9 and 10 ng/ml and
then subjected to continuous image capture for 48 h [2].
(4) Time-lapse microscopy and image processing. Images
will be obtained using an IXMicro microscope (Molecular
Devices, Sunnyvale, CA, USA). Each image showing a red
fluorescent signal from cyclin D1 and a green fluorescent
signal from GFAP will be processed using a low-pass
Gaussian filter and the Matlab function regionprops
followed by procedures similar to those described in Ref.
[33]. The algorithm will be performed in MATLAB
(MathWorks).
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Through the above procedures, the temporal changes
in cyclin D1 and GFAP will be measured. We will then
calculate the coefficient of variation (CV) for cyclin D1
in response to different doses of cholera toxin. Addition-
ally, we will calculate the correlation coefficient between
the CV of cyclin D1 and GFAP level after 24 h or 48 h
under the corresponding conditions. If this correlation
coefficient is close to -1, then the experimental data are
consistent with the model prediction that increasing
noise reduces glioma differentiation efficiency.
In our ongoing work, we will further investigate more
detailed molecular regulatory networks [34, 35] under-
lying the feedback loop of cyclin D1 activation. First, the
identification of such molecules [36] will advance our
understanding of the molecular mechanisms underlying
resistance to differentiation therapy. Second, when com-
bined with differentiation therapy, the identified proteins
(we will specify them) may be candidate targets for redu-
cing drug resistance [37].
Conclusions
We have investigated the functional role of stochastic
noise in the drug response and differentiation efficiency
during cancer differentiation therapy based on an experi-
mentally validated model. Our stochastic modeling of
glioma differentiation therapy as a realistic case study
demonstrated that increased noise can modulate the
ultrasensitivity of cyclin D1 activity and decrease the ef-
ficiency of drug-induced glioma differentiation. More-
over, the combination of differentiation-inducible drugs
and inhibition of cyclin D1 feedback can enhance the
differentiation efficiency of glioma cells. These results
advance our understanding of the relationship between
noise and drug efficacy in glioma differentiation. Add-
itionally, our study indicates the potential benefit of tar-
geting the dynamics of some critical molecules during
cancer therapy to increase anti-cancer effects.
Methods
Cell lines and agents
Human glioblastoma U87-MG cells were obtained from
the American Type Culture Collection (Manassas, VA).
8-(4-Chlorophenylthio)-adenosine-3′5′-cyclic monopho-
sphate sodium salt (8-CPT-cAMP) was purchased from
the BioLogLife Science Institute (Bermen, Germany) and
the CDK4/6 inhibitor PD 0332991 was purchased from
Selleckchem (Houston, TX).
Gene silencing using CCND1 siRNA
The siRNA fragments 001, 002 and 003 targeting human
CCND1 were purchased from Sigma-Aldrich (St Louis,
MO), and the sequences of these fragments were de-





CUAUUCUUACdTdT. CCND1 siRNA was transfected
into U87-MG cells using the Lipofectamine™ RNAi-
MAX reagent (Invitrogen, Carlsbad, California). After
1, 2 and 3 days, proteins from the transfected cells
were subjected to western blot analysis and the protein
levels of cyclin D1, GFAP and PCNA were evaluated
with specific antibodies.
Western blot analysis
U87-MG cells were treated with CCND1 siRNA, 8-CPT-
cAMP or CDK4/6 inhibitor for different times. Total
proteins were extracted with the Mammalian Protein
Extraction Reagent (Pierce, Rockford, IL, USA) and then
subjected to measurement of the protein concentration
with the BCA Protein AssayKit (Pierce, Rockford, IL,
USA). Next, equal amounts of the protein samples were
separated via sodiumdodecylsulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) and then electrotransferred
to a PVDF membrane. Primary antibodies against cyclin
D1, GPAP, PCNA (Cell Signaling Technology, Beverly,
MA, USA) and Tubulin (Sigma-Aldrich, St Louis, MO)
and a horseradish peroxidase-labeled secondary antibody
(Cell Signaling Technology, Beverly, MA, USA) were
used to recognize these specific proteins. Finally, the
proteins were visualized with enhanced chemilumines-
cence detection reagents (Pierce, Rockford, IL, USA) in
an immunoblotting imaging and analysis system
(BioRad, CA, USA).
Additive noise model
As a simple and the easiest approach for incorporating
molecular fluctuations in the model [16, 38], an additive
noise model (ANM) [39–42] that incorporates an addi-
tive noise term into the stochastic differential equation
was adopted in this study to simulate stochastic signal
transduction in the regulation of glioma differentiation.
The ANM model is described by the following
equations:
dY ¼ F t;Yð Þ⋅dt þ σ⋅dW ð3Þ
where Y = {yk, k = 1,⋯, 10} is a set of random variables
describing the activation levels of the molecular com-
ponents in the signaling pathway. The drift term, F(Y),
in the above model is a matrix consisting of functions
that describe chemical reaction rates between molecu-
lar components. The symbol σ represents the noise in-
tensity determining the amplitude of noise in the
system. The symbol W = {ωk(t), k = 1,⋯, 10} represents
a set of independent Wiener processes or standard
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Brownian motion, characterized by the following
equation:





N 0; 1ð Þ; k ¼ 1;⋯; 10: ð4Þ
where N(0,1) is the unit normal distribution.
The drug-induced activation of the PKA-PI3K-AKT-
GSK3β pathway (Fig. 1) is modeled by the following
equations (5–9) using Michaelis-Menten kinetics [43]
and Hill functions [44]:
d PKA½  ¼ a1dt þ V 1⋅CT
n1
K1 þ CTn1 dt−d1 PKA½ dt
þ σ1dW 1 ð5Þ
d CREB½  ¼ V 2⋅ PKA½ 
K 2 þ PKA½  dt−d2 CREB½ dt
þ σ2dW 2 ð6Þ
d PI3K½  ¼ 1
1þ PKA½ =K 3 dt−d3 PI3K½ dt
þ σ3dW 3 ð7Þ
d AKT½  ¼ V 4⋅ PI3K½ 
K4 þ PI3K½  dt−d4 AKT½ dt
þ σ4dW 4 ð8Þ
d pGSK3β½  ¼ V 5⋅ GSK3βT½ − pGSK3β½ ð Þ




−d5 pGSK3β½ dt þ σ5dW 5:
ð9Þ
The cAMP-PKA mediated activation of the IL-6-JAK2-
STAT3 pathway induced by CT is modeled as follows:
d IL6½  ¼ V 7⋅ PKA½ 
K7 þ PKA½  dt−d7 IL6½ dt þ σ7⋅dW 7 ð10Þ
d JAK2½  ¼ V 8⋅ IL6½ 
K8 þ IL6½  dt−d8 JAK2½ dt þ σ8⋅dW 8 ð11Þ
d STAT3½  ¼ V 9⋅ JAK2½ 
K9 þ JAK2½  dt−d9 STAT3½ dt
þ σ9⋅dW 9: ð12Þ
The stochastic kinetics of cyclin D1, balanced by its
activation and degradation, is modeled as follows:
d CyclinD1½  ¼ V 6⋅ CyclinD1½ 
n2





K 6b þ ½aGSK3β
⋅ CyclinD1½ 
 
dt þ σ6⋅dW 6
ð13Þ
where the first term on the right-hand side describes the
activation of cyclin D1 promoted by self-amplification or
a positive feedback loop for cyclin D1 [17, 18] that has
been validated in our previous study [5]. V6 is the maximal
activation rate of cyclin D1, and K6a is the Michaelis con-
stant. n2 is the Hill coefficient. The second term on the
right-hand side of the above equation describes the deacti-
vation of cyclin D1 induced by active GSK3β, which can
trigger cyclin D1 translocation and degradation. d6 is the
dephosphorylation rate of cyclin D1, and K6b is the
Michaelis constant for GSK3β-induced cyclin D1 degrad-
ation. W6 is standard Brownian motion, and σ6 is a diffu-
sion coefficient.
As a reliable marker of the differentiation of glioma
cells, GFAP is regulated by CREB, STAT3 and active
GSK3β [2, 4]. Degradation of cyclin D1 is required for
the differentiation of glioma cells [3]. Therefore, the sto-
chastic dynamics of GFAP can be modeled using the fol-
lowing equation:
d GFAP½  ¼ f 0 CyclinD1½ ð Þ⋅

V 10ab⋅ CREB½ 
K10a þ CREB½ ⋅
STAT3½ 
K10b þ STAT3½ 
þ V 10c⋅ aGSK3β½ 
n3
K10c þ aGSK3β½ n3

dt−d10 GFAP½ dt þ σ10dW 10
ð14Þ
where f 0 CyclinD1½ ð Þ ¼ C− CyclinD1½ C
 þ
with C being the
maximal value of the steady-state of cyclin D1, and
xð Þþ ¼ x; x > 0
0; x≤0

. As the upregulation of cyclin D1 is in-
dispensable in the cell cycle and cell proliferation, it is
only when cyclin D1 is downregulated that glioma cells
can begin to differentiate and, thus, that GFAP can be
unregulated. Therefore cyclin D1 is modeled as being
dominant in GFAP regulation. The involvement of
CREB, STAT3 and GSK3β in the regulation of GFAP is
modeled by determining the best fit of the model
structure to the experimental data under various con-
ditions [5]. The last two terms in the above equation
describe the degradation and fluctuations of GFAP.
Chemical-Langenvin-Equation (CLE) model
The variation in signal transduction arises from various
sources, including intrinsic and extrinsic factors [45].
The intrinsic factors include statistical mechanical fluc-
tuations in the diffusion and binding of the molecules
involved in protein activation. The extrinsic factors in-
clude fluctuations in the extracellular environment [46],
the stochasticity of gene expression [47], variations in
the epigenetic state [48], and different levels of molecu-
lar machines [45, 49], etc.
To examine the effects of intrinsic noise on glioma dif-
ferentiation, we also employed the CLE model to simu-
late the stochastic molecular responses of glioma cells to
drug treatment, and to extend the predictions of the
ANM model. Based on the deterministic ODE model,
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K 1 þ CTn1
s









¼ V 2⋅ PKA½ 





V 2⋅ PKA½ 
K2 þ PKA½ 
s



























¼ V 4⋅ PI3K½ 





V 4⋅ PI3K½ 
K4 þ PI3K½ 
s









¼ V 5⋅ GSK3βT½ − pGSK3β½ ð Þ








V 5⋅ GSK3βT½ − pGSK3β½ ð Þ
K5 þ GSK3βT½ − pGSK3β½ 
⋅ AKT½ 
 s













¼ V 7⋅ PKA½ 





V 7⋅ PKA½ 
K7 þ PKA½ 
s









¼ V 8⋅ IL6½ 





V 8⋅ IL6½ 
K8 þ IL6½ 
s









¼ V 9⋅ JAK2½ 





V 9⋅ JAK2½ 
K9 þ JAK2½ 
s









¼ V 6⋅ CyclinD1½ 
n2













K6an2 þ CyclinD1½ n2
 s





K 6b þ ½aGSK3β 
⋅ CyclinD1½ 
 s





¼ f 0 CyclinD1½ ð Þ⋅
 
V 10ab⋅ CREB½ 
K10a þ CREB½  ⋅
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f 0 CyclinD1½ ð Þ⋅

V 10ab⋅ CREB½ 




K10b þ STAT3½ 
þ V 10c⋅ aGSK3β½ 
n3
K10c þ aGSK3β½ n3

ζ 19−d10 GFAP½ ζ 20
	
ð24Þ
where V denotes the total number of molecules of each
protein in the above signaling pathway and ζi (i = 1,⋯, 20)
represents temporally uncorrelated, statistically independ-
ent Gaussian white noise, i.e., for each i, j = 1,⋯, 20,
ζ i tð Þζ j sð Þ

  ¼ 0; f or i≠j
δ t−sð Þ; f or i ¼ j

: ð25Þ
Furthermore, when extrinsic noise was taken into ac-
count, each parameter, Pj, in the model was varied as
Pj(1 + λεi), where εi (i = 1,⋯, 39) represents statistically
independent Gaussian white noise. λ is the strength of
the extrinsic noise.
The uniqueness of the solution to the above stochastic
differential equations (SDEs) can be guaranteed because
their coefficients satisfy certain appropriate growth con-
ditions and local Lipschitz continuity [51]. The biological
meaning of the applied parameters and their values are
listed in Additional file 1: Table S1. The initial values of
the mathematical model are listed in Additional file 1:
Table S2. We numerically solved the above SDEs using
the Euler-Maruyama method [52]. The simulation was
performed in MATLAB R2007b (Math Works, USA).
The trajectories of all signaling components in relation
to the noise simulated with the CLE model are presented
in Additional file 1: Figure S6.
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Parameter sensitivity analysis
Parameter sensitivity analysis is often used to quantita-
tively explore which parameters are more sensitive in af-
fecting signaling dynamics. The time-dependent sensitivity
coefficient of GFAP (model output) at time point t with re-
spect to parameter Pj was calculated as follows:










Time-averaged sensitivities [53] were calculated as
shown below to evaluate parameter sensitivity during








 = L; ð27Þ
where {tl, l = 1,⋯ L} is an equal partition of [0, T], with
L =100 and T = 48 h in the simulation. A small perturb-
ation (ΔPj =5 %) is imposed for calculating the time-
averaged sensitivities of GFAP with respect to the exam-
ined parameters.
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Additional file 1: Text S1. Cyclin D1 feedback increases variability in
signal transduction and phenotypic transition. Figure S1 Both the
downregulation of cyclin D1 expression and inhibition of the function of
the cyclin D1/CDK4/6 complex induce the differentiation of human
glioblastoma U87-MG cells into glia-like cells. Figure S2 Comparison
between the simulated time-course of GFAP levels at a 5 % noise
intensity and the experimental data. Figure S3 The coefficient of variation
of cyclin D1 and GFAP levels affected by cyclin D1 feedback during glioma
differentiation. Figure S4 The effect of inhibition of cyclin D1 feedback
simulated with the ANM model. Figure S5 The effect of inhibition of cyclin
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